{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:32:53Z","timestamp":1778103173849,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jpeds.2025.114574","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T03:00:21Z","timestamp":1743735621000},"page":"114574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Factors Associated with Antiviral Drug Use Among Commercially Insured Children at High Risk for Complications of Influenza"],"prefix":"10.1016","volume":"282","author":[{"given":"Abdullah","family":"Abdelaziz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2528-5458","authenticated-orcid":false,"given":"Jyotirmoy","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Wen","family":"Lien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos G.","family":"Grijalva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-2658","authenticated-orcid":false,"given":"James W.","family":"Antoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2025.114574_bib1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/irv.12994","article-title":"Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study","volume":"16","author":"Hartnett","year":"2022","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jpeds.2025.114574_bib2","first-page":"568","article-title":"Health care resource utilization and costs for influenza-like illness among Midwestern health plan members","volume":"21","author":"Klepser","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.jpeds.2025.114574_bib3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1542\/pir.2023-005962","article-title":"Influenza in children and adolescents: epidemiology, management, and prevention","volume":"44","author":"Wolf","year":"2023","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.jpeds.2025.114574_bib4","article-title":"Recommendations for prevention and control of influenza in children, 2021-2022","volume":"148","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2025.114574_bib5","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/cid\/cix1040","article-title":"Efficacy and safety of oseltamivir in children: systematic review and individual patient data meta-analysis of randomized controlled trials","volume":"66","author":"Malosh","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2025.114574_bib6","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","article-title":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials","volume":"385","author":"Dobson","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2025.114574_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.19151","article-title":"Comparison of antiviral agents for seasonal influenza outcomes in healthy adults and children: a systematic review and network meta-analysis","volume":"4","author":"Liu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpeds.2025.114574_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/13696998.2021.1889572","article-title":"Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs","volume":"24","author":"Wallick","year":"2021","journal-title":"J Med Econ"},{"key":"10.1016\/j.jpeds.2025.114574_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/dkg007","article-title":"Early administration of oral oseltamivir increases the benefits of influenza treatment","volume":"51","author":"Aoki","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jpeds.2025.114574_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/pds.5207","article-title":"Association of baloxavir marboxil prescription with subsequent medical resource utilization among school-aged children with influenza","volume":"30","author":"Takeuchi","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jpeds.2025.114574_bib11","first-page":"e88","article-title":"Baloxavir vs oseltamivir: reduced utilization and costs in influenza","volume":"28","author":"Neuberger","year":"2022","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jpeds.2025.114574_bib12","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/INF.0000000000002528","article-title":"Early administration of oseltamivir within 48 hours after onset of Flulike symptoms can reduce the risk of influenza B virus-associated pneumonia in hospitalized pediatric patients with influenza B virus infection","volume":"39","author":"Dai","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2025.114574_bib13","article-title":"Neuraminidase inhibitors for preventing and treating influenza in adults and children","volume":"2014","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpeds.2025.114574_bib14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical practice guidelines by the infectious diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2025.114574_bib15","article-title":"Recommendations for prevention and Control of influenza in children, 2024-2025: policy statement","volume":"154","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2025.114574_bib16","article-title":"Recommendations for prevention and Control of influenza in children, 2022-2023","volume":"150","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2025.114574_bib17","doi-asserted-by":"crossref","first-page":"e1040","DOI":"10.1093\/cid\/ciac606","article-title":"Guideline-concordant antiviral treatment in children at high risk for influenza complications","volume":"76","author":"Antoon","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2025.114574_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.8255","article-title":"Accuracy of influenza ICD-10 diagnosis codes in identifying influenza illness in children","volume":"7","author":"Antoon","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpeds.2025.114574_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/pds.5788","article-title":"Validity of ICD-10-based algorithms to identify patients with influenza in inpatient and outpatient settings","volume":"33","author":"Benack","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jpeds.2025.114574_bib20","article-title":"Recommendations for prevention and Control of influenza in children, 2023-2024","volume":"152","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2025.114574_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jpeds.2025.114574_bib23","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.15585\/mmwr.mm7345a2","article-title":"Underutilization of influenza antiviral treatment among children and adolescents at higher risk for influenza-associated complications - United States, 2023-2024","volume":"73","author":"Frutos","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpeds.2025.114574_bib24","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-061960","article-title":"Trends in outpatient influenza antiviral use among children and adolescents in the United States","volume":"152","author":"Antoon","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2025.114574_bib26","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jpeds.2025.114574_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/aje\/kws412","article-title":"The table 2 fallacy: presenting and interpreting confounder and modifier coefficients","volume":"177","author":"Westreich","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jpeds.2025.114574_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/ije\/dyaa260","article-title":"Reflection on modern methods: demystifying robust standard errors for epidemiologists","volume":"50","author":"Mansournia","year":"2021","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jpeds.2025.114574_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/pds.5728","article-title":"Optimizing large real-world data analysis with parquet files in R: a step-by-step tutorial","volume":"33","author":"Abdelaziz","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jpeds.2025.114574_bib31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jpids\/piy101","article-title":"Clinical features and outcomes of immunocompromised children hospitalized with laboratory-confirmed influenza in the United States, 2011-2015","volume":"8","author":"Collins","year":"2019","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.jpeds.2025.114574_bib32","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1067\/mpd.2000.110445","article-title":"The burden of influenza illness in children with asthma and other chronic medical conditions","volume":"137","author":"Neuzil","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2025.114574_bib33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/cid\/cit725","article-title":"The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts","volume":"58","author":"Memoli","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2025.114574_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpeds.2021.06.075","article-title":"Prevalence, risk factors, and outcomes of influenza-associated neurologic complications in children","volume":"239","author":"Antoon","year":"2021","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2025.114574_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6908a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2014 United States, 2020\u201321 influenza season","volume":"69","author":"Grohskopf","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jpeds.2025.114574_bib36","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/INF.0000000000004424","article-title":"Incidence of influenza-associated neurologic and psychiatric complications requiring hospitalization in children ages 5-17 years","volume":"43","author":"Quertermous","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2025.114574_bib37","doi-asserted-by":"crossref","first-page":"e1040","DOI":"10.1093\/cid\/ciac606","article-title":"Guideline-concordant antiviral treatment in children at high risk for influenza complications","volume":"76","author":"Antoon","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2025.114574_bib38","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2023.17244","article-title":"Influenza antiviral shortages reported by state and territorial public health officials, 2022-2023","volume":"330","author":"Kojima","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2025.114574_bib39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijantimicag.2013.10.025","article-title":"Outpatient influenza antiviral prescription trends with influenza-like illness in the USA, 2008-2010","volume":"43","author":"Suda","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jpeds.2025.114574_bib40","author":"Terrie"},{"key":"10.1016\/j.jpeds.2025.114574_bib42","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/cid\/civ146","article-title":"Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season","volume":"60","author":"Havers","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2025.114574_bib43","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/cid\/ciu422","article-title":"Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season","volume":"59","author":"Havers","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2025.114574_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad500.074","article-title":"1101. Antiviral prescription in children with influenza in emergency departments (ED): new vaccine surveillance network (NVSN), 2016\u20132020","volume":"10","author":"Stopczynski","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jpeds.2025.114574_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.849545","article-title":"Evaluation of the clinical effectiveness of oseltamivir for influenza treatment in children","volume":"13","author":"Qin","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpeds.2025.114574_bib46","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(24)01307-2","article-title":"Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials","volume":"404","author":"Gao","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2025.114574_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/jamainternmed.2023.0699","article-title":"Evaluation of oseltamivir used to prevent hospitalization in outpatients with influenza: a systematic review and meta-analysis","volume":"184","author":"Hanula","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jpeds.2025.114574_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/jamainternmed.2023.4720","article-title":"Oseltamivir may or may not reduce hospitalizations","volume":"184","author":"Antoon","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jpeds.2025.114574_bib50","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/INF.0000000000002747","article-title":"Baloxavir marboxil single-dose treatment in influenza-infected children: a randomized, double-blind, active controlled phase 3 safety and efficacy trial (miniSTONE-2)","volume":"39","author":"Baker","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2025.114574_bib51","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2025.114574_bib52","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S1473-3099(20)30004-9","article-title":"Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Ison","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jpeds.2025.114574_bib53","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/osp4.450","article-title":"Validated methods for identifying individuals with obesity in health care administrative databases: a systematic review","volume":"6","author":"Samadoulougou","year":"2020","journal-title":"Obes Sci Pract"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347625001143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347625001143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T16:35:35Z","timestamp":1749486935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347625001143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":48,"alternative-id":["S0022347625001143"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2025.114574","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors Associated with Antiviral Drug Use Among Commercially Insured Children at High Risk for Complications of Influenza","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2025.114574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114574"}}